Trials / Completed
CompletedNCT00837746
Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate
Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Risedronate Daily or Weekly
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 29 (actual)
- Sponsor
- Warner Chilcott · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study analysed and reported on the study data from three similar, risedronate studies, 1996052, 2003073, and 2003096. The objective of the study was to determine the differences in the iliac crest bone histomorphometry and bone quality in postmenopausal women who had received long term therapy with risedronate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | risedronate | risedronate tablet, 5 mg daily or 35 mg once weekly for 5 years |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2006-10-01
- Completion
- 2006-10-01
- First posted
- 2009-02-05
- Last updated
- 2013-06-05
Locations
8 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00837746. Inclusion in this directory is not an endorsement.